Description
PathGen Diagnostik Teknologi was established in early 2020, initiated by Susanti, with the aim of fostering a portfolio of research and training activities in collaboration with counterparts in Indonesia. The company's primary focus is on the development of low-cost and robust molecular diagnostic tools, as well as capacity building to effectively deliver these technologies. PathGen Diagnostik Teknologi is located and incubated at the Center of Innovation within the Indonesian Institute of Sciences (Lembaga Pengetahuan Indonesia/LIPI), which is a government research body in Indonesia.
Our VIsion and MIssion:
Vision
“Global equity in precision medicine”
Mission
“Providing low-cost molecular diagnostics for cancer and other diseases in Indonesia and engaging in capacity building through knowledge exchange with the global partners.
